How Did the Blood Testing Ternose Thing Work Out?

2min Snip

00:00

Play full episode

Summary

Transcript

Episode notes

About 40 per cent, thirty to forty per cent of our companies are biotac and medical devices. A consumer's off ware, like a snapchap. And so codiac is a eye drug that prevents you from going blind from a macular degeneration. How did the blood testing ternose thing work out? Ha, ha, ha, know, we ever. Fortunately, you, unfortunately, they were about ten ye they started ten years before we did. Missed it....

1:00 Jason intros Power of Accelerators Episode 2!
3:07 Jason intros StartX Founder Cameron Teitelman: What is StartX, how do they invest, when and how was it started?
6:54 How does StartX exist? Are they profitable?
8:43 Why would a growth stage founder join StartX?
13:28 What is the process for selecting founders/companies for StartX? What is unique about Stanford students?
16:28 Difference between arrogance and confidence, StartX's "No A**hole" rule, Cohort size
20:47 What does StartX look for in founders, what questions are asked in interviews & what preferences do they have regarding co-founders
27:04 How do VCs look at StartX? What are their demo days like?
31:54 Thoughts on YC's demo day & how to run a demo day process
41:16 Cameron on hacking his way into VC, new StartX funds, thesis on successful founders & peer-support groups
45:58 Stories about getting cut out of a deal
48:09 What StartX's portfolio signaling tells them about successful founders, importance of time management
51:59 Steve Blank's theory of customer development, top portfolio companies